MannKind (MNKD) News
NASDAQ: MNKDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.29-0.13 (-3.80%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MNKD news summary
We found 1 recent headline mentioning MannKind (MNKD): 1 in the past week and 1 in the past 30 days, most often from GlobeNewswire. For price context, MNKD is down 3.80% at $3.29. The most recent story, "MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)", was published by GlobeNewswire on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology